GlobalPrediktor
← Market overview

Research

Today's markets, and any stock or coin explained in plain language.

ABT · NYQ

Abbott Laboratories

98.73USD+0.58%
Today's range97.62 – 99.37
52-week range81.97 – 135.24

Key numbers

Market value
$170.08B

What the whole company is worth on the stock market.

P/E ratio
31.8

Price ÷ last year's profit per share. Higher means investors pay more for each $1 of profit.

Forward P/E
16.3

The same ratio using next year's expected profit.

Beta
0.5830

How much the stock swings compared with the market: 1 moves like the market, 1.5 moves 50% more.

Dividend yield
2.55%

Yearly dividend as a share of the price.

What analysts say

28 analysts

Strong buy: 5Buy: 19Hold: 4Sell: 0Strong sell: 0
Average price target120.72 +22.27% vs today's price

Recent analyst actions

2026-10-07 · BarclaysOverweight
2026-10-02 · Rothschild & CoNeutral → Buy
2026-09-08 · TD CowenBuy
2026-08-25 · TD CowenBuy
2026-08-21 · TD CowenBuy
2026-08-14 · CitigroupBuy

Financial health

Piotroski F-Score
6/9

Nine checks of profitability, debt and efficiency. 7–9 strong, 4–6 average, 0–3 weak.

Altman Z-Score
4.74 · Safe zone

A bankruptcy-risk score. Above 3 is the safe zone, 1.8–3 grey, below 1.8 distress.

Profitability and debt

Revenue, last 12 months$46.58B
Revenue growth+13.0%
Gross margin56.8%
Operating margin14.7%
Net margin11.6%
Return on equity10.6%
Free cash flow$7.21B
Debt to equity63%
Current ratio1.38

Short-term assets ÷ short-term debts. Below 1 means more due within a year than on hand.

Fair value (DCF model)

A discounted-cash-flow model: what future cash flows are worth today. It is a model, not a promise.

Pessimistic
58.59
Base case
69.61
Optimistic
78.06
Margin of safety
-29.5%

Compared with similar companies

The company next to its sector peers.

CompanyPriceP/EP/BMarket value
LLYEli Lilly and Company1,188.7241.538.3$1.11T
JNJJohnson & Johnson258.4529.86.1$626.26B
ABBVAbbVie Inc.271.3674.794.4$471.27B
MRKMerck & Company, Inc.142.79110.75.0$351.20B
UNHUnitedHealth Group Incorporated375.9824.13.2$340.11B
TMOThermo Fisher Scientific Inc662.0635.44.1$246.83B
AMGNAmgen Inc.413.0825.320.4$221.52B
ABTAbbott Laboratories98.7331.44.2$170.08B
PFEPfizer, Inc.28.0036.91.6$159.68B
BMYBristol-Myers Squibb Company59.7013.25.9$122.45B
Sector average42.318.3

About the company

SectorHealthcare
IndustryMedical Devices
Employees122,000
CountryUnited States

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hemato…

Data: Elcaro Core (Yahoo Finance, Binance, Treasury) · Information, not investment advice.